2015
Quetiapine in children and adolescents with subaverage IQ
Jou R, Handen B, Hardan A. Quetiapine in children and adolescents with subaverage IQ. Journal Of Pediatric Neurology 2015, 03: 035-039. DOI: 10.1055/s-0035-1557235.Peer-Reviewed Original ResearchTolerability of quetiapineSpecialized outpatient clinicConners' Parent Rating ScaleExperienced sedationConcomitant medicationsAdverse eventsChart reviewOutpatient clinicRetrospective studyTreatment durationParent Rating ScaleSame caregiverHyperactivity subscaleQuetiapinePatientsRating ScaleMental retardationSubaverage IQMedicationsMaintenance periodChildrenAdolescentsSubscalesTolerabilitySedation
2005
Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders
Hardan A, Jou R, Handen B. Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders. Journal Of Autism And Developmental Disorders 2005, 35: 387-391. PMID: 16119479, DOI: 10.1007/s10803-005-3306-1.Peer-Reviewed Original ResearchConceptsRetrospective studyPervasive developmental disorderTolerability of quetiapinePlacebo-controlled studyDevelopmental disordersAdverse eventsChart reviewConsecutive outpatientsTreatment terminationQuetiapineHyperactivity subscaleDevelopmental disabilitiesDisordersChildrenAdolescentsParent scaleTolerabilitySedationPatientsOutpatientsClinicResponders
2004
Psychostimulant treatment of adults with mental retardation and attention‐deficit hyperactivity disorder
Jou R, Handen B, Hardan A. Psychostimulant treatment of adults with mental retardation and attention‐deficit hyperactivity disorder. Australasian Psychiatry 2004, 12: 376-379. DOI: 10.1111/j.1440-1665.2004.02130.x.Peer-Reviewed Original ResearchAttention deficit hyperactivity disorderHyperactivity disorderTreatment of ADHDTolerability of psychostimulantsAberrant Behavior Checklist-Community VersionChart reviewMental retardationDouble-blind placebo-controlled studyProspective open-label studyPsychostimulant treatmentClinical Global Impression ScaleDevelopmental disabilitiesOpen-label studyPlacebo-controlled studyConsecutive adult outpatientsIrritability subscaleRetrospective chart reviewGlobal Impression ScaleGlobal improvement itemTreatment terminationAdverse eventsAdult outpatientsImpression ScaleAdultsPsychostimulantsPsychostimulant Treatment of Adults With Mental Retardation and Attention-Deficit Hyperactivity Disorder
Jou R, Handen B, Hardan A. Psychostimulant Treatment of Adults With Mental Retardation and Attention-Deficit Hyperactivity Disorder. Australasian Psychiatry 2004, 12: 376-379. PMID: 15715811, DOI: 10.1080/j.1440-1665.2004.02130.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmphetamineAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsClinical Trials as TopicDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationHumansIntellectual DisabilityIrritable MoodMethylphenidateMotor ActivityPersonality AssessmentQuality of LifeSocial BehaviorTreatment OutcomeConceptsAttention deficit hyperactivity disorderAberrant Behavior Checklist-Community VersionHyperactivity disorderTreatment of ADHDTolerability of psychostimulantsChart reviewMental retardationDouble-blind placebo-controlled studyProspective open-label studyPsychostimulant treatmentClinical Global Impression ScaleDevelopmental disabilitiesOpen-label studyPlacebo-controlled studyConsecutive adult outpatientsIrritability subscaleRetrospective chart reviewGlobal Impression ScaleGlobal improvement itemTreatment terminationAdverse eventsAdult outpatientsImpression ScaleAdultsPsychostimulants